Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

93 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Hofmeister Effect Mediated Strong PHEMA-Gelatin Hydrogel Actuator.
Li J, Chee HL, Chong YT, Chan BQY, Xue K, Lim PC, Loh XJ, Wang F. Li J, et al. Among authors: lim pc. ACS Appl Mater Interfaces. 2022 May 16. doi: 10.1021/acsami.2c01922. Online ahead of print. ACS Appl Mater Interfaces. 2022. PMID: 35575697
Reversible Tuning of Mie Resonances in the Visible Spectrum.
Lu L, Dong Z, Tijiptoharsono F, Ng RJH, Wang H, Rezaei SD, Wang Y, Leong HS, Lim PC, Yang JKW, Simpson RE. Lu L, et al. Among authors: lim pc. ACS Nano. 2021 Dec 28;15(12):19722-19732. doi: 10.1021/acsnano.1c07114. Epub 2021 Dec 9. ACS Nano. 2021. PMID: 34881865
Exploring Reusability of Disposable Face Masks: Effects of Disinfection Methods on Filtration Efficiency, Breathability, and Fluid Resistance.
Teo JY, Kng J, Periaswamy B, Liu S, Lim PC, Lee CE, Tan BH, Loh XJ, Ni X, Tiang D, Yi G, Ong YY, Ling ML, Wan WY, Wong HM, How M, Xin X, Zhang Y, Yang YY. Teo JY, et al. Among authors: lim pc. Glob Chall. 2021 Jul 28;5(11):2100030. doi: 10.1002/gch2.202100030. eCollection 2021 Nov. Glob Chall. 2021. PMID: 34754506 Free PMC article.
Development and validation of patient diabetes knowledge questionnaire (PDKQ).
Lim PC, Rajah R, Lim YL, Kam JLH, Wong TY, Krishnanmurthi V, Chang CT, Cheah MT, Kamaruzzaman ND, Tan WT, Lee ES, Zainal H. Lim PC, et al. J Pharm Policy Pract. 2023 Oct 19;16(1):121. doi: 10.1186/s40545-023-00631-3. J Pharm Policy Pract. 2023. PMID: 37858279 Free PMC article.
A phase III, multicenter, randomized study of olvimulogene nanivacirepvec followed by platinum-doublet chemotherapy and bevacizumab compared with platinum-doublet chemotherapy and bevacizumab in women with platinum-resistant/refractory ovarian cancer.
Holloway RW, Thaker P, Mendivil AA, Ahmad S, Al-Niaimi AN, Barter J, Beck T, Chambers SK, Coleman RL, Crafton SM, Crane E, Ramez E, Ghamande S, Graybill W, Herzog T, Indermaur MD, John VS, Landrum L, Lim PC, Lucci JA, McHale M, Monk BJ, Moore KN, Morris R, O'Malley DM, Reid TJ, Richardson D, Rose PG, Scalici JM, Silasi DA, Tewari K, Wang EW. Holloway RW, et al. Among authors: lim pc. Int J Gynecol Cancer. 2023 Sep 4;33(9):1458-1463. doi: 10.1136/ijgc-2023-004812. Int J Gynecol Cancer. 2023. PMID: 37666539 Clinical Trial.
93 results